|
- 2019
Management of local recurrences and regional failure in early stage non-small cell lung cancer after stereotactic body radiation therapyAbstract: Stereotactic body radiation therapy (SBRT) is the standard of care in early-stage non-small cell lung cancer (NSCLC) for medically inoperable patients. SBRT has a 5-year infield control of over 90% and a 5-year loco-regional control of approximately 75% (1). In defining cancer specific outcomes, patterns of recurrence become important. We define local recurrence as being at the site of treatment (within the initial PTV), regional failure as being in the chest outside the treated PTV in the same lobe of the lung or mediastinal nodal failures
|